腰薦根病變市場規模、佔有率和成長分析：按治療類型、給藥途徑、分銷管道、最終用戶和地區分類－2026-2033年產業預測

2024 年全球腰薦神經根疼痛市場價值為 9 億美元，預計到 2033 年將從 2025 年的 9.5 億美元成長至 14.8 億美元，預測期（2026-2033 年）的複合年成長率為 5.7%。

全球腰薦神經根病變市場的發展主要受腰椎神經根受壓迫有效治療需求的驅動，該疾病影響全球約5%的成年人。該市場涵蓋藥品、微創醫療設備和復健服務，並因對鴉片類藥物濫用的擔憂而逐漸轉向類固醇注射和射頻消融術等非侵入性療法。 CT和超音波導引等影像導引介入技術的應用顯著提高了治療效果，提高了手術精度並縮短了恢復時間，從而增加了醫院間的手術量和報銷率。這一趨勢為開發導航軟體和一次性手術包的公司帶來了進一步的成長機會。診斷技術的進步以及有利的報銷政策正在推動全球市場的顯著擴張。

全球腰薦神經根疼痛市場的成長要素

全球老化導致退化性疾病盛行率不斷上升，顯著推動了全球腰薦神經根病變市場的需求。這種人口結構的變化使得越來越多的患者尋求有效的腰薦神經根病治療方法，促使醫療服務提供者更加重視先進的症狀管理策略。因此，影像診斷、藥物治療和微創介入治療的需求日益成長。對老齡化相關神經病變機制的持續研究正在推動治療方法的創新，而市場格局也在不斷發展，這主要得益於人們對緩解慢性神經疼痛日益成長的需求。

全球腰薦神經根疼痛市場的限制因素

在全球腰薦神經根病變市場，資金限制嚴重阻礙了脊椎內視鏡、導航系統和可程式設計神經刺激設備等先進醫療技術的應用。許多醫療機構，尤其是公立醫院和開發中國家的醫院，面臨預算限制，被迫依賴傳統手術方法，而非採用創新解決方案。這種不願投資最尖端科技的心理源於降低成本的需求，導致儘管醫生對微創治療方案的興趣日益濃厚，但有效療法的引入卻被延誤。因此，醫療管理者在將資源分配給新技術之前，必須仔細評估投資報酬率。

全球腰薦神經根疼痛市場趨勢

隨著微創手術的優勢日益凸顯，全球腰薦神經根病變市場正經歷著微創手術技術的顯著轉變。微創手術的優點包括手術時間短、併發症少、病人康復快，這些優點正逐漸被人們所認知。這一趨勢促使醫療機構投資於先進的影像技術和專業培訓，從而推動了切除術切除術和內視鏡減壓術等手術的廣泛應用。隨著這些技術的普及，它們在當地醫療機構的可及性也將得到提升，使醫療服務提供者能夠從競爭對手中脫穎而出，並滿足患者對無痛治療的需求，最終為市場創造新的成長機會。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球腰薦根管疼痛市場規模：依治療類型分類

• 藥物治療
  • 物理治療
  • 脊骨神經醫學療法
  • 針刺
• 非藥物治療
• 干預療法
  • 硬脊膜外類固醇注射
  • 神經阻斷
  • 脊髓刺激療法
  • 手術介入

全球腰薦根管疼痛市場規模：依給藥途徑分類

• 口服
• 外用
• 注射藥物
• 嵌入式

全球腰薦根管疼痛市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球腰薦根管疼痛市場規模：依最終用戶分類

• 醫院
• 專科診所
• 復健中心
• 居家照護環境

全球腰薦根管疼痛市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic PLC
• Boston Scientific Corporation
• Nevro Corp.
• SPR Therapeutics LLC
• Abbott Neuromodulation
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Globus Medical, Inc.
• NuVasive, Inc.
• Orthofix Medical Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Bayer AG
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Mallinckrodt Pharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• Lupin Limited
• Eli Lilly and Company
• AstraZeneca PLC

結論與建議

Global Lumbosacral Radicular Pain Market size was valued at USD 0.9 Billion in 2024 and is poised to grow from USD 0.95 Billion in 2025 to USD 1.48 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global market for lumbosacral radicular pain is driven by a need for effective treatments targeting lower spine nerve-root compression, affecting approximately 5% of adults globally. The market includes pharmaceuticals, minimally invasive devices, and rehabilitation services, shifting focus from opioids due to concerns about misuse towards non-invasive solutions like steroid injections and radiofrequency ablation. The adoption of imaging-guided interventions, such as CT or ultrasound-guided procedures, significantly enhances treatment outcomes by improving accuracy and reducing recovery times, subsequently boosting procedural volumes and reimbursement rates within hospitals. This trend presents additional market growth opportunities for companies creating navigation software and disposable kits. Together, advancements in diagnostic techniques and favorable reimbursement policies are propelling significant market expansion on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lumbosacral Radicular Pain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lumbosacral Radicular Pain Market Segments Analysis

Global lumbosacral radicular pain market is segmented by treatment type, route of administration, distribution channel, end user and region. Based on treatment type, the market is segmented into pharmacological treatment, non-pharmacological treatment and interventional procedures. Based on route of administration, the market is segmented into oral, topical, injectable and implantable. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end user, the market is segmented into hospitals, specialty clinics, rehabilitation centers and homecare settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lumbosacral Radicular Pain Market

The increasing prevalence of degenerative spinal conditions among the aging population worldwide is significantly driving the demand for the Global Lumbosacral Radicular Pain market. This demographic shift has led to a growing number of patients seeking effective treatment options for lumbosacral radicular pain, prompting healthcare providers to focus on advanced symptom management strategies. Consequently, there is a heightened need for diagnostic imaging, pharmacological therapies, and minimally invasive interventions. The ongoing research into age-related neuropathic processes fosters innovation in treatment approaches, contributing to a dynamic market landscape fueled by the rising pursuit of relief from chronic nerve pain.

Restraints in the Global Lumbosacral Radicular Pain Market

In the Global Lumbosacral Radicular Pain market, financial constraints significantly hinder the adoption of advanced medical technologies such as spinal endoscopy, navigation systems, and programmable neurostimulators. Many healthcare providers, especially in public hospitals and developing countries, face budgetary restrictions that force them to rely on traditional surgical methods instead of embracing innovative solutions. This reluctance to invest in cutting-edge technology stems from the need to minimize costs, resulting in a slower integration of effective treatments despite a growing physician interest in less invasive options. Consequently, healthcare administrators must carefully evaluate the return on investment before allocating resources to new technological advancements.

Market Trends of the Global Lumbosacral Radicular Pain Market

The Global Lumbosacral Radicular Pain market is experiencing a notable shift towards the adoption of minimally invasive surgical techniques, driven by the increasing recognition of their advantages, such as reduced operative time, fewer complications, and expedited recovery periods for patients. This trend is propelling medical centers to invest in advanced imaging technologies and specialized training, enabling wider implementation of procedures like microdiscectomy and endoscopic decompression. As these techniques become more prevalent, they enhance accessibility in regional care facilities, empower healthcare providers to distinguish themselves from competitors, and address patient demand for less painful treatment options, ultimately creating new growth opportunities within the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Lumbosacral Radicular Pain Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological Treatment
  • Physical Therapy
  • Chiropractic Care
  • Acupuncture
• Non-Pharmacological Treatment
• Interventional Procedures
  • Epidural Steroid Injections
  • Nerve Blocks
  • Spinal Cord Stimulation
  • Surgical Intervention

Global Lumbosacral Radicular Pain Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Topical
• Injectable
• Implantable

Global Lumbosacral Radicular Pain Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Lumbosacral Radicular Pain Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Rehabilitation Centers
• Homecare Settings

Global Lumbosacral Radicular Pain Market Size & CAGR (2026-2033)

• North America (Treatment Type, Route of Administration, Distribution Channel, End User)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Neuromodulation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations